Lidocaine for Migraine

"The latest information on clinicaltrials.gov suggests that this study is still recruiting patients. The posting date was October 15th, 2018 and the last edit was December 31st, 2020. They are looking for a total of 50 participants at 1 location."

"In order to participate in this clinical trial, applicants must be aged between 10 and 20 years old. There are 103 other studies for people who fall outside of that age range and are either under 18 or over 65."

"This study is in need of 50 individuals, aged 10-20, who have a history of migraines. Furthermore, it is essential that potential participants meet the following conditions: Patients must be unresponsive to oral painkillers as decided by their treating physician., The headache must rank moderate to severe on the NRS scale with a score of 6 or higher, Headache duration should fall between 2 and 72 hours, Headache should not originate from the occipital region (frontal, frontotemporal, or unilateral), pulsating or throbbing quality, aggravated by or causing avoidance of routine physical activity, nausea, vomiting, or both"

"Lidocaine can be used to safely and effectively mitigate increased intra ocular pressure (iop), nasal irritation, and increased renal excretion of harmful substances."

"That is accurate, the online clinicaltrials.gov registry shows that this study is open and actively recruiting patients. The listing was created on 10/15/2018 and updated on 12/31/2020. They are looking to enroll 50 individuals at a single site."

"Lidocaine is being researched in 235 active clinical trials, 60 of which are Phase 3. The majority of research sites for Lidocaine are located in Duarte, California; though, there are 1,475 total locations conducting trials for this medication."

"Our analysts have given Lidocaine a score of 3 out of 3 for safety. This is because Phase 3 trials usually have some data to support efficacy as well as multiple rounds of data affirming safety."